Avacta Group Plc (AVCT.L) Stock Price
£40.2 0%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
1 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Avacta Group Plc, AI stock picks, stock alerts and much more.
AVCT.L AI Stock Analysis
AI stock analysis for AVCT.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Avacta Group Plc (AVCT.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Avacta Group Plc (AVCT.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Avacta Group Plc (AVCT.L), currently trading at £40.2, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About AVCT.L
-
Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe.
-
Symbol
AVCT.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
149.9M
Similar Stocks
 |
Codexis 0I0X.L |
$2.58 2% |
3 |
 |
Oxford Nanopore Technologies plc ONT.L |
£111.5 1.7% |
5 |
 |
Sareum Holdings SAR.L |
£12.5 0.00% |
3 |
 |
Viridian Therapeutics 0K1R.L |
$15.35 0.2% |
5 |
 |
ImmuPharma IMM.L |
£3.5 4.8% |
4 |
News
AVCT.L Alternative Data
Web Traffic
Avacta Group Plc receives an estimated 4499 monthly visitors to avacta.com.
-
Web Traffic
4499
-
Change from Previous Month
2.5%
-
3 Month Change
1.6%
-
YoY Change
1.6%
News Mentions
Avacta Group Plc was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
Twitter Followers
Avacta Group Plc has 8,512 Twitter Followers on its main Twitter (also known as X) account, which is up by 0% over the last month.
-
Twitter Followers
8512
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.2%
Job Postings
Avacta Group Plc currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Avacta Group Plc has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
LinkedIn Employees
According to LinkedIn, Avacta Group Plc has 45 employees, up by 2.3% over the last month.
-
LinkedIn Employees
45
-
Daily Change
0%
-
1 Month Change
2.3%
-
3 Month Change
4.3%
LinkedIn Followers
6,805 are following Avacta Group Plc on LinkedIn.
-
LinkedIn Followers
6805
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Avacta Group Plc is 37 out of 100 (bearish).
-
Business Outlook
37
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
AVCT.L Financials
AVCT.L Key Metrics
-
Total Revenue
£11.3M
-
Net Income
-£12.5M
-
Earnings per Share
-£0.0382
-
Free cash flow
-£13M
-
EBITDA
-£4.5M
-
EBITDA Ratio
-0.400142
-
Total Assets
£89.3M
AVCT.L 2-year Revenue & Income
AVCT.L 2-year Free Cash Flow
AVCT.L Technicals
AVCT.L SMA
AVCT.L RSI
FAQ
What's the current price of Avacta Group Plc (AVCT.L) Stock?
The price of an Avacta Group Plc (AVCT.L) share is £40.2.
What's the market cap of Avacta Group Plc?
The current market cap of Avacta Group Plc is 149.9M.
Should I buy or sell AVCT.L?
Avacta Group Plc exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Avacta Group Plc a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Avacta Group Plc stock. There are several bearish signals and market challenges that could negatively impact Avacta Group Plc's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Avacta Group Plc (AVCT.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Avacta Group Plc stock right now, as the outlook appears bearish.
What are some stocks similar to Avacta Group Plc (AVCT.L) that investors often compare it to?
Avacta Group Plc (AVCT.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and ImmuPharma.
What is the forecast for Avacta Group Plc's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Avacta Group Plc's stock price to be around £36.65 in 2026. Starting from the current price of £40.2, this represents a 8.8% change in price, indicating a bearish outlook for the stock.
How to buy Avacta Group Plc (AVCT.L) Stock?
Avacta Group Plc stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Avacta Group Plc shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.